Valeo Health secures $12 million Series B to scale AI-personalised healthcare

🧪 UAE-based Valeo Health has raised $12 million in a Series B round to scale its personalised, AI-powered wellness platform across the GCC. The raise brings its total funding to $20 million since launch.

• The round was led by Flintera, with participation from Nuwa Capital, FJ Labs, Oryx, Mindshift Capital, and new backers Oraseya and Eirad.

Valeo was co-founded in 2021 by Sundeep Sahni, Nadine Karadag, and Ankur Majumder. Sahni is a third-time founder who previously co-founded Lazada and HelloPay – both acquired by Alibaba for $3 billion.

⏪ Background

The company was born from a simple but powerful insight: most people aren’t acutely sick – but they also don’t feel their best.

To fill this gap, the team launched a wellness platform that enables users to track key health data, order at-home blood tests, receive AI-guided insights, and connect with certified coaches.

As demand for proactive, preventative health services grows in the region, Valeo offers a more consumer-first alternative to traditional medical systems – one that fits into people’s homes and lifestyles.

❌ The size of the problem

Across MENA, most healthcare systems still focus on treating illness, not preventing it.

While telemedicine and diagnostics have improved, there’s a significant gap in ongoing health optimisation – especially for users looking to improve energy, sleep, mood, or nutrition.

At the same time, wellness services are often fragmented, unscientific, or unregulated. This makes it harder for users to take control of their long-term health in a structured way.

Valeo’s integrated approach – data + diagnostics + coaching – offers a clear value prop: evidence-backed care that goes beyond reactive medicine.

📖 What does the company do?

The platform offers:

• At-home testing for key biomarkers like hormones, vitamins, cholesterol, and food intolerances

• Longevity programs powered by AI and real-time data

• Certified health coaches to guide behaviour change

• Supplements and IV therapy delivered to your door

Its app provides users with tailored health plans, tracks longitudinal improvements, and uses AI to offer predictive insights.

The model is designed to empower everyday users – not just patients – with actionable, medically sound recommendations.

🔮 Outlook

Valeo has already gained traction in the UAE and KSA, and with the new backing it’s primed for broader GCC expansion.

• Its most relevant global peer? Think Levels (US) or Thriva (UK) – but localised for MENA’s health and cultural context.